Debiopharm is a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs.

Oncology is the group’s main area of expertise, though it also develops drugs for specific indications in the immunology and infectious diseases sectors.